Advanced search
Publication Cover
Neuropsychiatric Disease and Treatment Volume 13, 2017 - Issue
Submit an article Journal homepage
180
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Efficacy and tolerability of escitalopram in treatment of major depressive disorder with anxiety symptoms: a 24-week, open-label, prospective study in Chinese population

Kaida Jiang1 Psychiatry Department, Shanghai Mental Health Center, Shanghai
,
Lingjiang Li2 Psychiatry Department,The Second Xiangya Hospital, Central South University, Changsha
,
Xueyi Wang3 Psychiatry Department, First affiliated Hospital of Hebei Medical University, Shijiazhuang
,
Maosheng Fang4 Psychiatry Department, Wuhan Mental Health Center, Wuhan
,
Jianfei Shi5 Psychiatry Department, Hangzhou the 7th Hospital, Hangzhou
,
Qiuyun Cao6 Psychology Department, Nanjing Drum Tower Hospital, Nanjing
,
Jincai He7 Neurology Department, First affiliated Hospital of Wenzhou Medical University, Wenzhou
,
Jinan Wang8 Medical Affairs Department, Xi’an Janssen Pharmaceutical Ltd., Beijing, People’s Republic of China
,
Weihao Tan8 Medical Affairs Department, Xi’an Janssen Pharmaceutical Ltd., Beijing, People’s Republic of China
&
Cuili Hu8 Medical Affairs Department, Xi’an Janssen Pharmaceutical Ltd., Beijing, People’s Republic of ChinaCorrespondence[email protected]
 show all
Pages 515-526 | Published online: 17 Feb 2017

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Ramadan Saleh, Ahmad Majzoub & Mohammed Abu El-Hamd. (2021) An update on the treatment of premature ejaculation: A systematic review. Arab Journal of Urology 19:3, pages 281-302.
Read now
Gang Wang, Xiumin You, Xueyi Wang, Xiufeng Xu, Ludong Bai, Jian Xie, Zhijian Yao, QiZhong Yi, Jun Ma, Jinan Wang, Jianmin Zhuo & Cuili Hu. (2018) Safety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety. Neuropsychiatric Disease and Treatment 14, pages 2087-2097.
Read now

Articles from other publishers (10)

Yuelee Khoo, Ilya Demchenko, Benicio N. Frey, Roumen V. Milev, Arun V. Ravindran, Sagar V. Parikh, Keith Ho, Susan Rotzinger, Wendy Lou, Raymond W. Lam, Sidney H. Kennedy & Venkat Bhat. (2022) Baseline anxiety, and early anxiety/depression improvement in anxious depression predicts treatment outcomes with escitalopram: A CAN-BIND-1 study report. Journal of Affective Disorders 300, pages 50-58.
Crossref
SoniaShinde Mahajan, Manu Arora, VishalR Tandon, Annil Mahajan & Suman Kotwal. (2022) Improvement in quality of life of postmenopausal women with depression with commonly used antidepressants (Escitalopram vs. Desvenlafaxine): A randomized controlled trial in a tertiary care teaching hospital of North India. Journal of Mid-life Health 13:1, pages 80.
Crossref
Tatiyana Mandal, Laxminarayana Kurady Bairy, Podila Satya Venkata Narasimha Sharma & Vijaya Lakshmi Valaparla. (2021) Impact of gender, depression severity and type of depressive episode on efficacy and safety of escitalopram: an observational study on major depressive disorder patients in southern India. The Egyptian Journal of Neurology, Psychiatry and Neurosurgery 57:1.
Crossref
Madhavi Kodali, Srikanth Lella, Sarath Bodepudi, Therissa Benerji & Krishna Mohan Parvathaneni. (2021) Effectiveness and side-effect profile of Vilazodone and Escitalopram in major Depressive Disorder – An observational study. IP Indian Journal of Neurosciences 7:1, pages 20-25.
Crossref
Toktam Sadat Firoozeei, Majid Barekatain, Mehrdad Karimi, Arman Zargaran, Shahin Akhondzadeh & Hossein Rezaeizadeh. (2020) Lavender and dodder combined herbal syrup versus citalopram in major depressive disorder with anxious distress: A double-blind randomized trial. Journal of Integrative Medicine 18:5, pages 409-415.
Crossref
Yifeng Shen, Qian Zhao, Yimin Yu, Yunlong Tan, Honggeng Zhang, Xiufeng Xu, Zhiyang Wang, Yan Li, Jingqiu Hu, Jinhua Zhong & Huafang Li. (2019) Efficacy and safety of bupropion hydrochloride extended-release versus escitalopram oxalate in Chinese patients with major depressive disorder: Results from a randomized, double-blind, non-inferiority trial. Journal of Affective Disorders 257, pages 143-149.
Crossref
Mark Zimmerman, Sophie Kerr, Reina Kiefer, Caroline Balling & Kristy Dalrymple. (2019) What is anxious depression? Overlap and agreement between different definitions. Journal of Psychiatric Research 109, pages 133-138.
Crossref
Ji-hua Xu & Peng Jiang. (2018) Efficacy of escitalopram oxalate for patients with post-stroke depression. Medicine 97:14, pages e0219.
Crossref
Roxanne Gaspersz, Laura Nawijn, Femke Lamers & Brenda W.J.H. Penninx. (2018) Patients with anxious depression. Current Opinion in Psychiatry 31:1, pages 17-25.
Crossref
Guanjun Li, Yifeng Shen, Jianfeng Luo & Huafang Li. (2017) Efficacy of escitalopram monotherapy in the treatment of major depressive disorder. Medicine 96:39, pages e8142.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.